4-[5-(5-methoxy-6-propan-2-yl-3-pyridinyl)-1,2,4-oxadiazol-3-yl]morpholine;4-[5-(5-methoxy-6-propan-2-yl-3-pyridinyl)-1,3,4-oxadiazol-2-yl]morpholine;4-[1-[5-(5-methoxy-6-propan-2-yl-3-pyridinyl)-1,3,4-oxadiazol-2-yl]piperidin-4-yl]morpholine;4-[5-(6-propan-2-yl-3-pyridinyl)-1,2,4-oxadiazol-3-yl]morpholine;4-[1-[5-(6-propan-2-yl-3-pyridinyl)-1,2,4-oxadiazol-3-yl]piperidin-4-yl]morpholine;4-[1-[5-(6-propan-2-yl-3-pyridinyl)-1,3,4-oxadiazol-2-yl]piperidin-4-yl]morpholine

C102H141N27O15 — CID 163652066

IUPAC4-[5-(5-methoxy-6-propan-2-yl-3-pyridinyl)-1,2,4-oxadiazol-3-yl]morpholine;4-[5-(5-methoxy-6-propan-2-yl-3-pyridinyl)-1,3,4-oxadiazol-2-yl]morpholine;4-[1-[5-(5-methoxy-6-propan-2-yl-3-pyridinyl)-1,3,4-oxadiazol-2-yl]piperidin-4-yl]morpholine;4-[5-(6-propan-2-yl-3-pyridinyl)-1,2,4-oxadiazol-3-yl]morpholine;4-[1-[5-(6-propan-2-yl-3-pyridinyl)-1,2,4-oxadiazol-3-yl]piperidin-4-yl]morpholine;4-[1-[5-(6-propan-2-yl-3-pyridinyl)-1,3,4-oxadiazol-2-yl]piperidin-4-yl]morpholine
SMILESCC(C)c1ccc(-c2nc(N3CCC(N4CCOCC4)CC3)no2)cn1.CC(C)c1ccc(-c2nc(N3CCOCC3)no2)cn1.CC(C)c1ccc(-c2nnc(N3CCC(N4CCOCC4)CC3)o2)cn1.COc1cc(-c2nc(N3CCOCC3)no2)cnc1C(C)C.COc1cc(-c2nnc(N3CCC(N4CCOCC4)CC3)o2)cnc1C(C)C.COc1cc(-c2nnc(N3CCOCC3)o2)cnc1C(C)C
InChIInChI=1S/C20H29N5O3.2C19H27N5O2.2C15H20N4O3.C14H18N4O2/c1-14(2)18-17(26-3)12-15(13-21-18)19-22-23-20(28-19)25-6-4-16(5-7-25)24-8-10-27-11-9-24;1-14(2)17-4-3-15(13-20-17)18-21-22-19(26-18)24-7-5-16(6-8-24)23-9-11-25-12-10-23;1-14(2)17-4-3-15(13-20-17)18-21-19(22-26-18)24-7-5-16(6-8-24)23-9-11-25-12-10-23;1-10(2)13-12(20-3)8-11(9-16-13)14-17-18-15(22-14)19-4-6-21-7-5-19;1-10(2)13-12(20-3)8-11(9-16-13)14-17-15(18-22-14)19-4-6-21-7-5-19;1-10(2)12-4-3-11(9-15-12)13-16-14(17-20-13)18-5-7-19-8-6-18/h12-14,16H,4-11H2,1-3H3;2*3-4,13-14,16H,5-12H2,1-2H3;2*8-10H,4-7H2,1-3H3;3-4,9-10H,5-8H2,1-2H3
InChIKeyINASJNIHRWDVEK-UHFFFAOYSA-N
MW1985.42 g/mol
LogP13.97
Rot. Bonds24

About 4-[5-(5-methoxy-6-propan-2-yl-3-pyridinyl)-1,2,4-oxadiazol-3-yl]morpholine;4-[5-(5-methoxy-6-propan-2-yl-3-pyridinyl)-1,3,4-oxadiazol-2-yl]morpholine;4-[1-[5-(5-methoxy-6-propan-2-yl-3-pyridinyl)-1,3,4-oxadiazol-2-yl]piperidin-4-yl]morpholine;4-[5-(6-propan-2-yl-3-pyridinyl)-1,2,4-oxadiazol-3-yl]morpholine;4-[1-[5-(6-propan-2-yl-3-pyridinyl)-1,2,4-oxadiazol-3-yl]piperidin-4-yl]morpholine;4-[1-[5-(6-propan-2-yl-3-pyridinyl)-1,3,4-oxadiazol-2-yl]piperidin-4-yl]morpholine

4-[5-(5-methoxy-6-propan-2-yl-3-pyridinyl)-1,2,4-oxadiazol-3-yl]morpholine;4-[5-(5-methoxy-6-propan-2-yl-3-pyridinyl)-1,3,4-oxadiazol-2-yl]morpholine;4-[1-[5-(5-methoxy-6-propan-2-yl-3-pyridinyl)-1,3,4-oxadiazol-2-yl]piperidin-4-yl]morpholine;4-[5-(6-propan-2-yl-3-pyridinyl)-1,2,4-oxadiazol-3-yl]morpholine;4-[1-[5-(6-propan-2-yl-3-pyridinyl)-1,2,4-oxadiazol-3-yl]piperidin-4-yl]morpholine;4-[1-[5-(6-propan-2-yl-3-pyridinyl)-1,3,4-oxadiazol-2-yl]piperidin-4-yl]morpholine (PubChem CID 163652066) has the molecular formula C102H141N27O15 and a molecular weight of 1985.42 g/mol. Its IUPAC name is 4-[5-(5-methoxy-6-propan-2-yl-3-pyridinyl)-1,2,4-oxadiazol-3-yl]morpholine;4-[5-(5-methoxy-6-propan-2-yl-3-pyridinyl)-1,3,4-oxadiazol-2-yl]morpholine;4-[1-[5-(5-methoxy-6-propan-2-yl-3-pyridinyl)-1,3,4-oxadiazol-2-yl]piperidin-4-yl]morpholine;4-[5-(6-propan-2-yl-3-pyridinyl)-1,2,4-oxadiazol-3-yl]morpholine;4-[1-[5-(6-propan-2-yl-3-pyridinyl)-1,2,4-oxadiazol-3-yl]piperidin-4-yl]morpholine;4-[1-[5-(6-propan-2-yl-3-pyridinyl)-1,3,4-oxadiazol-2-yl]piperidin-4-yl]morpholine.

Molecular Properties

Compound Name4-[5-(5-methoxy-6-propan-2-yl-3-pyridinyl)-1,2,4-oxadiazol-3-yl]morpholine;4-[5-(5-methoxy-6-propan-2-yl-3-pyridinyl)-1,3,4-oxadiazol-2-yl]morpholine;4-[1-[5-(5-methoxy-6-propan-2-yl-3-pyridinyl)-1,3,4-oxadiazol-2-yl]piperidin-4-yl]morpholine;4-[5-(6-propan-2-yl-3-pyridinyl)-1,2,4-oxadiazol-3-yl]morpholine;4-[1-[5-(6-propan-2-yl-3-pyridinyl)-1,2,4-oxadiazol-3-yl]piperidin-4-yl]morpholine;4-[1-[5-(6-propan-2-yl-3-pyridinyl)-1,3,4-oxadiazol-2-yl]piperidin-4-yl]morpholine
PubChem CID163652066
Molecular FormulaC102H141N27O15
Molecular Weight1985.42 g/mol
Exact Mass1984.11
IUPAC Name4-[5-(5-methoxy-6-propan-2-yl-3-pyridinyl)-1,2,4-oxadiazol-3-yl]morpholine;4-[5-(5-methoxy-6-propan-2-yl-3-pyridinyl)-1,3,4-oxadiazol-2-yl]morpholine;4-[1-[5-(5-methoxy-6-propan-2-yl-3-pyridinyl)-1,3,4-oxadiazol-2-yl]piperidin-4-yl]morpholine;4-[5-(6-propan-2-yl-3-pyridinyl)-1,2,4-oxadiazol-3-yl]morpholine;4-[1-[5-(6-propan-2-yl-3-pyridinyl)-1,2,4-oxadiazol-3-yl]piperidin-4-yl]morpholine;4-[1-[5-(6-propan-2-yl-3-pyridinyl)-1,3,4-oxadiazol-2-yl]piperidin-4-yl]morpholine
SMILESCC(C)c1ccc(-c2nc(N3CCC(N4CCOCC4)CC3)no2)cn1.CC(C)c1ccc(-c2nc(N3CCOCC3)no2)cn1.CC(C)c1ccc(-c2nnc(N3CCC(N4CCOCC4)CC3)o2)cn1.COc1cc(-c2nc(N3CCOCC3)no2)cnc1C(C)C.COc1cc(-c2nnc(N3CCC(N4CCOCC4)CC3)o2)cnc1C(C)C.COc1cc(-c2nnc(N3CCOCC3)o2)cnc1C(C)C
InChIInChI=1S/C20H29N5O3.2C19H27N5O2.2C15H20N4O3.C14H18N4O2/c1-14(2)18-17(26-3)12-15(13-21-18)19-22-23-20(28-19)25-6-4-16(5-7-25)24-8-10-27-11-9-24;1-14(2)17-4-3-15(13-20-17)18-21-22-19(26-18)24-7-5-16(6-8-24)23-9-11-25-12-10-23;1-14(2)17-4-3-15(13-20-17)18-21-19(22-26-18)24-7-5-16(6-8-24)23-9-11-25-12-10-23;1-10(2)13-12(20-3)8-11(9-16-13)14-17-18-15(22-14)19-4-6-21-7-5-19;1-10(2)13-12(20-3)8-11(9-16-13)14-17-15(18-22-14)19-4-6-21-7-5-19;1-10(2)12-4-3-11(9-15-12)13-16-14(17-20-13)18-5-7-19-8-6-18/h12-14,16H,4-11H2,1-3H3;2*3-4,13-14,16H,5-12H2,1-2H3;2*8-10H,4-7H2,1-3H3;3-4,9-10H,5-8H2,1-2H3
InChIKeyINASJNIHRWDVEK-UHFFFAOYSA-N
XLogP13.97
TPSA423.09 Ų
H-Bond Donors
H-Bond Acceptors42
Rotatable Bonds24
Heavy Atoms144
Complexity—

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5001985.42
LogP ≤ 513.97
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 1042

Analyze 4-[5-(5-methoxy-6-propan-2-yl-3-pyridinyl)-1,2,4-oxadiazol-3-yl]morpholine;4-[5-(5-methoxy-6-propan-2-yl-3-pyridinyl)-1,3,4-oxadiazol-2-yl]morpholine;4-[1-[5-(5-methoxy-6-propan-2-yl-3-pyridinyl)-1,3,4-oxadiazol-2-yl]piperidin-4-yl]morpholine;4-[5-(6-propan-2-yl-3-pyridinyl)-1,2,4-oxadiazol-3-yl]morpholine;4-[1-[5-(6-propan-2-yl-3-pyridinyl)-1,2,4-oxadiazol-3-yl]piperidin-4-yl]morpholine;4-[1-[5-(6-propan-2-yl-3-pyridinyl)-1,3,4-oxadiazol-2-yl]piperidin-4-yl]morpholine with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of 4-[5-(5-methoxy-6-propan-2-yl-3-pyridinyl)-1,2,4-oxadiazol-3-yl]morpholine;4-[5-(5-methoxy-6-propan-2-yl-3-pyridinyl)-1,3,4-oxadiazol-2-yl]morpholine;4-[1-[5-(5-methoxy-6-propan-2-yl-3-pyridinyl)-1,3,4-oxadiazol-2-yl]piperidin-4-yl]morpholine;4-[5-(6-propan-2-yl-3-pyridinyl)-1,2,4-oxadiazol-3-yl]morpholine;4-[1-[5-(6-propan-2-yl-3-pyridinyl)-1,2,4-oxadiazol-3-yl]piperidin-4-yl]morpholine;4-[1-[5-(6-propan-2-yl-3-pyridinyl)-1,3,4-oxadiazol-2-yl]piperidin-4-yl]morpholine?
The IUPAC name of 4-[5-(5-methoxy-6-propan-2-yl-3-pyridinyl)-1,2,4-oxadiazol-3-yl]morpholine;4-[5-(5-methoxy-6-propan-2-yl-3-pyridinyl)-1,3,4-oxadiazol-2-yl]morpholine;4-[1-[5-(5-methoxy-6-propan-2-yl-3-pyridinyl)-1,3,4-oxadiazol-2-yl]piperidin-4-yl]morpholine;4-[5-(6-propan-2-yl-3-pyridinyl)-1,2,4-oxadiazol-3-yl]morpholine;4-[1-[5-(6-propan-2-yl-3-pyridinyl)-1,2,4-oxadiazol-3-yl]piperidin-4-yl]morpholine;4-[1-[5-(6-propan-2-yl-3-pyridinyl)-1,3,4-oxadiazol-2-yl]piperidin-4-yl]morpholine (CID 163652066) is 4-[5-(5-methoxy-6-propan-2-yl-3-pyridinyl)-1,2,4-oxadiazol-3-yl]morpholine;4-[5-(5-methoxy-6-propan-2-yl-3-pyridinyl)-1,3,4-oxadiazol-2-yl]morpholine;4-[1-[5-(5-methoxy-6-propan-2-yl-3-pyridinyl)-1,3,4-oxadiazol-2-yl]piperidin-4-yl]morpholine;4-[5-(6-propan-2-yl-3-pyridinyl)-1,2,4-oxadiazol-3-yl]morpholine;4-[1-[5-(6-propan-2-yl-3-pyridinyl)-1,2,4-oxadiazol-3-yl]piperidin-4-yl]morpholine;4-[1-[5-(6-propan-2-yl-3-pyridinyl)-1,3,4-oxadiazol-2-yl]piperidin-4-yl]morpholine.
What is the SMILES notation for 4-[5-(5-methoxy-6-propan-2-yl-3-pyridinyl)-1,2,4-oxadiazol-3-yl]morpholine;4-[5-(5-methoxy-6-propan-2-yl-3-pyridinyl)-1,3,4-oxadiazol-2-yl]morpholine;4-[1-[5-(5-methoxy-6-propan-2-yl-3-pyridinyl)-1,3,4-oxadiazol-2-yl]piperidin-4-yl]morpholine;4-[5-(6-propan-2-yl-3-pyridinyl)-1,2,4-oxadiazol-3-yl]morpholine;4-[1-[5-(6-propan-2-yl-3-pyridinyl)-1,2,4-oxadiazol-3-yl]piperidin-4-yl]morpholine;4-[1-[5-(6-propan-2-yl-3-pyridinyl)-1,3,4-oxadiazol-2-yl]piperidin-4-yl]morpholine?
The canonical SMILES for 4-[5-(5-methoxy-6-propan-2-yl-3-pyridinyl)-1,2,4-oxadiazol-3-yl]morpholine;4-[5-(5-methoxy-6-propan-2-yl-3-pyridinyl)-1,3,4-oxadiazol-2-yl]morpholine;4-[1-[5-(5-methoxy-6-propan-2-yl-3-pyridinyl)-1,3,4-oxadiazol-2-yl]piperidin-4-yl]morpholine;4-[5-(6-propan-2-yl-3-pyridinyl)-1,2,4-oxadiazol-3-yl]morpholine;4-[1-[5-(6-propan-2-yl-3-pyridinyl)-1,2,4-oxadiazol-3-yl]piperidin-4-yl]morpholine;4-[1-[5-(6-propan-2-yl-3-pyridinyl)-1,3,4-oxadiazol-2-yl]piperidin-4-yl]morpholine is CC(C)c1ccc(-c2nc(N3CCC(N4CCOCC4)CC3)no2)cn1.CC(C)c1ccc(-c2nc(N3CCOCC3)no2)cn1.CC(C)c1ccc(-c2nnc(N3CCC(N4CCOCC4)CC3)o2)cn1.COc1cc(-c2nc(N3CCOCC3)no2)cnc1C(C)C.COc1cc(-c2nnc(N3CCC(N4CCOCC4)CC3)o2)cnc1C(C)C.COc1cc(-c2nnc(N3CCOCC3)o2)cnc1C(C)C.
What is the InChIKey of 4-[5-(5-methoxy-6-propan-2-yl-3-pyridinyl)-1,2,4-oxadiazol-3-yl]morpholine;4-[5-(5-methoxy-6-propan-2-yl-3-pyridinyl)-1,3,4-oxadiazol-2-yl]morpholine;4-[1-[5-(5-methoxy-6-propan-2-yl-3-pyridinyl)-1,3,4-oxadiazol-2-yl]piperidin-4-yl]morpholine;4-[5-(6-propan-2-yl-3-pyridinyl)-1,2,4-oxadiazol-3-yl]morpholine;4-[1-[5-(6-propan-2-yl-3-pyridinyl)-1,2,4-oxadiazol-3-yl]piperidin-4-yl]morpholine;4-[1-[5-(6-propan-2-yl-3-pyridinyl)-1,3,4-oxadiazol-2-yl]piperidin-4-yl]morpholine?
The InChIKey is INASJNIHRWDVEK-UHFFFAOYSA-N. The full InChI is InChI=1S/C20H29N5O3.2C19H27N5O2.2C15H20N4O3.C14H18N4O2/c1-14(2)18-17(26-3)12-15(13-21-18)19-22-23-20(28-19)25-6-4-16(5-7-25)24-8-10-27-11-9-24;1-14(2)17-4-3-15(13-20-17)18-21-22-19(26-18)24-7-5-16(6-8-24)23-9-11-25-12-10-23;1-14(2)17-4-3-15(13-20-17)18-21-19(22-26-18)24-7-5-16(6-8-24)23-9-11-25-12-10-23;1-10(2)13-12(20-3)8-11(9-16-13)14-17-18-15(22-14)19-4-6-21-7-5-19;1-10(2)13-12(20-3)8-11(9-16-13)14-17-15(18-22-14)19-4-6-21-7-5-19;1-10(2)12-4-3-11(9-15-12)13-16-14(17-20-13)18-5-7-19-8-6-18/h12-14,16H,4-11H2,1-3H3;2*3-4,13-14,16H,5-12H2,1-2H3;2*8-10H,4-7H2,1-3H3;3-4,9-10H,5-8H2,1-2H3.
What are the key properties of 4-[5-(5-methoxy-6-propan-2-yl-3-pyridinyl)-1,2,4-oxadiazol-3-yl]morpholine;4-[5-(5-methoxy-6-propan-2-yl-3-pyridinyl)-1,3,4-oxadiazol-2-yl]morpholine;4-[1-[5-(5-methoxy-6-propan-2-yl-3-pyridinyl)-1,3,4-oxadiazol-2-yl]piperidin-4-yl]morpholine;4-[5-(6-propan-2-yl-3-pyridinyl)-1,2,4-oxadiazol-3-yl]morpholine;4-[1-[5-(6-propan-2-yl-3-pyridinyl)-1,2,4-oxadiazol-3-yl]piperidin-4-yl]morpholine;4-[1-[5-(6-propan-2-yl-3-pyridinyl)-1,3,4-oxadiazol-2-yl]piperidin-4-yl]morpholine?
4-[5-(5-methoxy-6-propan-2-yl-3-pyridinyl)-1,2,4-oxadiazol-3-yl]morpholine;4-[5-(5-methoxy-6-propan-2-yl-3-pyridinyl)-1,3,4-oxadiazol-2-yl]morpholine;4-[1-[5-(5-methoxy-6-propan-2-yl-3-pyridinyl)-1,3,4-oxadiazol-2-yl]piperidin-4-yl]morpholine;4-[5-(6-propan-2-yl-3-pyridinyl)-1,2,4-oxadiazol-3-yl]morpholine;4-[1-[5-(6-propan-2-yl-3-pyridinyl)-1,2,4-oxadiazol-3-yl]piperidin-4-yl]morpholine;4-[1-[5-(6-propan-2-yl-3-pyridinyl)-1,3,4-oxadiazol-2-yl]piperidin-4-yl]morpholine has a molecular weight of 1985.42 g/mol, XLogP of 13.97, 24 rotatable bonds, 0 hydrogen bond donors, and 42 hydrogen bond acceptors.
Where does this data come from?
All data for 4-[5-(5-methoxy-6-propan-2-yl-3-pyridinyl)-1,2,4-oxadiazol-3-yl]morpholine;4-[5-(5-methoxy-6-propan-2-yl-3-pyridinyl)-1,3,4-oxadiazol-2-yl]morpholine;4-[1-[5-(5-methoxy-6-propan-2-yl-3-pyridinyl)-1,3,4-oxadiazol-2-yl]piperidin-4-yl]morpholine;4-[5-(6-propan-2-yl-3-pyridinyl)-1,2,4-oxadiazol-3-yl]morpholine;4-[1-[5-(6-propan-2-yl-3-pyridinyl)-1,2,4-oxadiazol-3-yl]piperidin-4-yl]morpholine;4-[1-[5-(6-propan-2-yl-3-pyridinyl)-1,3,4-oxadiazol-2-yl]piperidin-4-yl]morpholine is sourced from PubChem (CID 163652066), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).